Robeco Institutional Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Robeco Institutional Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$894K	Hold	26,398	–	–	﹤0.01%	733
2026 Q1	$795K	Buy	26,398 +16,658	+171%	+$536K	﹤0.01%	762
2025 Q4	$304K	Buy	+9,740	New	+$240K	﹤0.01%	797
2025 Q1	–	Sell	-498,309	Closed	-$11M	–	929
2024 Q4	$11M	Buy	498,309 +33,277	+7%	+$605K	0.02%	437
2024 Q3	$8.38M	Buy	465,032 +197,585	+74%	+$3.46M	0.02%	465
2024 Q2	$4.35M	Buy	267,447 +160,616	+150%	+$2.47M	0.01%	561
2024 Q1	$1.51M	Buy	106,831 +31,271	+41%	+$394K	﹤0.01%	729
2023 Q4	$789K	Hold	75,560	–	–	﹤0.01%	803
2023 Q3	$771K	Sell	75,560 -56,776	-43%	-$529K	﹤0.01%	805
2023 Q2	$996K	Buy	132,336 +41,438	+46%	+$336K	﹤0.01%	786
2023 Q1	$804K	Hold	90,898	–	–	﹤0.01%	803
2022 Q4	$829K	Buy	+90,898	New	+$793K	﹤0.01%	796

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Robeco Institutional Asset Management's TEVA Position: Q2 2026 in Review

Robeco Institutional Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 26,398 shares worth $894K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Robeco Institutional Asset Management first reported a position in TEVA in Q4 2022 and has held it in 12 quarters since. The position peaked at $11M in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Robeco Institutional Asset Management held 26,398 shares of Teva Pharmaceuticals worth $894K as of Q2 2026.
Robeco Institutional Asset Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #733 holding.
Robeco Institutional Asset Management first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
Robeco Institutional Asset Management's Teva Pharmaceuticals position peaked at $11M in Q4 2024.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.